A pseudo-plaque method for infectious particle assay and clonal isolation of adeno-associated virus

Journal of Virological Methods

Volumn 170, Issue 1-2, 2010, Pages 9-15

  Mitchell, Daniel A J ^a   Lerch, Thomas F ^b   Hare, Joan T ^a   Chapman, Michael S ^b  

^a FLORIDA STATE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

AAV; Adeno associated virus; Assay; Plaque

Indexed keywords

MONOCLONAL ANTIBODY;

ADENO ASSOCIATED VIRUS; AGAR MEDIUM; ARTICLE; CELL STRAIN; COLORIMETRY; CONTROLLED STUDY; ENZYME MECHANISM; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR PROBE; MONOLAYER CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS CULTURE; VIRUS DETECTION; VIRUS GENOME; VIRUS ISOLATION; VIRUS PARTICLE;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; COLORIMETRY; DEPENDOVIRUS; HELA CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; MICROBIAL VIABILITY; PLAQUE ASSAY; POLYMERASE CHAIN REACTION; VIRAL LOAD; VIRION; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS;

EID: 78249259676     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.08.004     Document Type: Article

References (33)

1. Aucoin M.G., Perrier M., Kamen A.A. Critical assessment of current adeno-associated viral vector production and quantification methods. Biotechnol. Adv. 2008, 26:73-88.
2. Carter B.J. Variant and defective interfering parvoviruses. The Parvoviruses 1984, 209. Plenum Press, New York. K.I. Berns (Ed.).
3. Clark K.R., Liu X., McGrath J.P., Johnson P.R. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 1999, 10:1031-1039.
4. Debelak D., Fisher J., Iuliano S., Sesholtz D., Sloane D.L., Atkinson E.M. Cation-exchange high-performance liquid chromatography of recombinant adeno-associated virus type 2. J. Chromatogr. B: Biomed. Sci. Appl. 2000, 740:195-202.
5. Dulbecco R. Production of plaques in monolayer tissue cultures by single particles of an animal virus. Proc. Natl. Acad. Sci. U.S.A. 1952, 38:747-752.
6. Gao G.P., Wilson J.M., Wivel N.A. Production of recombinant adeno-associated virus. Adv. Virus Res. 2000, 55:529-543.
7. Grimm D., Kern A., Pawlita M., Ferrari F., Samulski R., Kleinschmidt J. Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. Gene Ther. 1999, 6:1322-1330.
8. Grimm D., Kern A., Rittner K., Kleinschmidt J.A. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 1998, 9:2745-2760.
9. Hohmann A.W., Faulkner P. Monoclonal antibodies to baculovirus structural proteins: determination of specificities by Western blot analysis. Virology 1983, 125:432-444.
10. Jurvansuu J., Fragkos M., Ingemarsdotter C., Beard P. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling. J. Mol. Biol. 2007, 372:397-406.
11. Parvoviruses 2006, Hodder Arnold, Ltd., London. J.R. Kerr, S.F. Cotmore, M.E. Bloom, R.M. Linden, C.R. Parrish (Eds.).
12. Lackner D.F., Muzyczka N. Studies of the mechanism of transactivation of the adeno-associated virus p19 promoter by Rep protein. J. Virol. 2002, 76:8225-8235.
13. Laughlin C.A., Tratschin J.D., Coon H., Carter B.J. Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 1983, 23:65-73.
14. Matsushita T., Elliger S., Elliger C., Podsakoff G., Villarreal L., Kurtzman G.J., Iwaki Y., Colosi P. Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther. 1998, 5:938-945.
15. Mayginnes J.P., Reed S.E., Berg H.G., Staley E.M., Pintel D.J., Tullis G.E. Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR. J. Virol. Methods 2006, 137:193-204.
16. Monsma S.A., Blissard G.W. Identification of a membrane fusion domain and an oligomerization domain in the baculovirus GP64 envelope fusion protein. J. Virol. 1995, 69:2583-2595.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
18. Mouw M.B., Pintel D.J. Adeno-associated virus RNAs appear in a temporal order and their splicing is stimulated during coinfection with adenovirus. J. Virol. 2000, 74:9878-9888.
19. Muzyczka N., Berns K.I. Parvoviridae: the viruses and their replication. Virology 2001, 2327-2360. Lippincott Williams & Wilkins, Philadelphia. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
20. Pereira D.J., McCarty D.M., Muzyczka N. The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection. J. Virol. 1997, 71:1079-1088.
21. Qiao C., Li J., Skold A., Zhang X., Xiao X. Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes. J. Virol. 2002, 76:1904-1913.
22. Rohr U.P., Wulf M.A., Stahn S., Steidl U., Haas R., Kronenwett R. Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. J. Virol. Methods 2002, 106:81-88.
23. Salvetti A. Factors influencing recombinant adeno-associated virus production. Hum. Gene Ther. 1998, 9:695-706.
24. Sambrook J., Russel W.D. Molecular Cloning: A Laboratory Manual 2001, CSHL Press, Cold Spring Harbor.
25. Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
26. Sommer J.J., Smith P.H., Parthasarathy S., Isaacs J., Vijay S., Kieran J., Powell S.K., McClelland A., Wright J.F. Quantification of adeno-associated virus particles and empty capsids by optical density measurement. Mol. Ther. 2003, 7:122-128.
27. Veldwijk M.R., Topaly J., Laufs S., Hengge U.R., Wenz F., Zeller W.J., Fruehauf S. Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks. Mol. Ther. 2002, 6:272-278.
28. Weger S., Wistuba A., Grimm D., Kleinschmidt J.A. Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats and rep proteins. VIIth International Parvovirus Workshop 1997, p. P27.
29. Wobus C.E., Hugle-Dorr B., Girod A., Petersen G., Hallek M., Kleinschmidt J.A. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J. Virol. 2000, 74:9281-9293.
30. Wu P., Xiao W., Conlon T., Hughes J., Agbandje-McKenna M., Ferkol T., Flotte T., Muzyczka N. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J. Virol. 2000, 74:8635-8647.
31. Xie Q., Hare J., Turnigan J., Chapman M.S. Large-scale production, purification and crystallization of wild-type adeno-associated virus-2. J. Virol. Methods 2004, 122:17-27.
32. Yakobson B., Koch T., Winocour E. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J. Virol. 1987, 61:972-981.
33. Zolotukhin S., Byrne B., Mason E., Zolotukhin I., Potter M., Chesnut K., Summerford C., Samulski R., Muzyczka N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 1999, 6:973-985.